Two new analyses raise questions about mortality rate of bird flu

In an analysis (.pdf) published Thursday in the online edition of the journal Science, a team led by virologist Peter Palese of Mount Sinai School of Medicine in New York argue the mortality rate from H5N1 bird flu is under one percent, much lower than the WHO's estimated fatality rate of 59 percent, Reuters reports. And in a paper published Friday in mBio, the journal of the American Society for Microbiology, Michael Osterholm of the University of Minnesota and a member of the U.S. National Science Advisory Board for Biosecurity (NSABB) and a colleague "conclude that H5N1 kills up to 80 percent of people it infects," a rate higher than WHO estimates, according to the news agency.

The studies "ad[d] fuel to the heated controversy over publication of bird flu research" in the journals Science and Nature describing how two teams created H5N1 strains that are easily transmissible among ferrets, which are used as lab models for humans, Reuters writes (Begley, 2/23). Fears that terrorists possibly could use the information prompted the U.S. National Science Advisory Board for Biosecurity in December to request the scientists redact some information prior to publishing their study results and investigators in January to institute a 60-day moratorium on bird flu research, USA Today's "Your Life" notes. "A WHO summit that ended this week called for full publication of the two studies and for an extended halt to such research until stronger safety measures were assured in labs," the blog writes (Vergano, 2/23).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New design could make seasonal influenza vaccinations more broadly effective